Jixiang Liu

1.0k total citations
46 papers, 591 citations indexed

About

Jixiang Liu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jixiang Liu has authored 46 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jixiang Liu's work include Pulmonary Hypertension Research and Treatments (7 papers), Cancer-related molecular mechanisms research (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Jixiang Liu is often cited by papers focused on Pulmonary Hypertension Research and Treatments (7 papers), Cancer-related molecular mechanisms research (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Jixiang Liu collaborates with scholars based in China, United States and United Kingdom. Jixiang Liu's co-authors include Jolene A. Bradford, Gayle Buller, Wesley Chang, James D. Hirsch, Ching-Ying Cheung, Anca Rothe, Stephen Yue, Brian Filanoski, Richard P. Haugland and William G. Telford and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Jixiang Liu

39 papers receiving 579 citations

Peers

Jixiang Liu

BIOPH

PRM

Tilen Koklič Slovenia

Lídia M. Andrade Brazil

Yuri Matsumoto Japan

Hongtao Chen China

Emma Scholefield United Kingdom

Gudrun H. Borchert Germany

Alexandra Sorvina Australia

Mitsuhiro Takeda Japan

Angelico Bedini Italy

Tilen Koklič Slovenia

Jixiang Liu

260 ×1.0

96 ×0.8

138 ×1.7

87 ×1.2

BIOPH

41 ×0.6

PRM

Citations per year, relative to Jixiang Liu Jixiang Liu (= 1×) peers Tilen Koklič

Countries citing papers authored by Jixiang Liu

Since Specialization

Citations

This map shows the geographic impact of Jixiang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jixiang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jixiang Liu more than expected).

Fields of papers citing papers by Jixiang Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jixiang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jixiang Liu. The network helps show where Jixiang Liu may publish in the future.

Co-authorship network of co-authors of Jixiang Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jixiang Liu. A scholar is included among the top collaborators of Jixiang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jixiang Liu. Jixiang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Jixiang, et al.. (2025). Gut microbiota, metabolites, and pulmonary hypertension: Mutual regulation and potential therapies. Microbiological Research. 299. 128245–128245. 3 indexed citations

Li, Haobo, Min Liu, Jixiang Liu, et al.. (2025). Dysregulation of immune cells and platelet-monocyte aggregates in chronic thromboembolic pulmonary hypertension. Respiratory Research. 26(1). 245–245.

Zhang, Haobing, Xiaohong Lu, Zhiyong Guo, et al.. (2025). Development of a clinically relevant rat model of chronic thromboembolic pulmonary hypertension by combining splenectomy with pulmonary thromboembolism. Thrombosis Research. 249. 109310–109310. 1 indexed citations

Chen, Shengsong, Jixiang Liu, Jia Ju, et al.. (2024). Hypoxia inducible factor (HIF) 3α prevents COPD by inhibiting alveolar epithelial cell ferroptosis via the HIF-3α-GPx4 axis. Theranostics. 14(14). 5512–5527. 9 indexed citations

Yang, Sen, Pingping Han, Huan Li, et al.. (2024). Evaluating the efficacy of balloon pulmonary angioplasty using quantitative analysis of SPECT pulmonary ventilation/perfusion scintigraphy in patients with chronic thromboembolic pulmonary hypertension. Quantitative Imaging in Medicine and Surgery. 14(3). 2590–2602. 2 indexed citations

Zhang, Chenchen, et al.. (2024). Exploration of Berberine Against Ulcerative Colitis via TLR4/NF-κB/HIF-1α Pathway by Bioinformatics and Experimental Validation. Drug Design Development and Therapy. Volume 18. 2847–2868. 5 indexed citations

Liu, Min, Jixiang Liu, Shuang Liu, et al.. (2024). A case report of empyema caused by Enterococcus gallinarum. BMC Infectious Diseases. 24(1). 769–769. 2 indexed citations

Wang, Jinzhi, Jixiang Liu, Xincao Tao, et al.. (2023). Safety and efficacy of balloon pulmonary angioplasty for technically operable chronic thromboembolic pulmonary hypertension. Pulmonary Circulation. 14(1). e12327–e12327. 5 indexed citations

Wang, Che, et al.. (2023). Hyperuricemia as an independent risk factor for metabolic dysfunction-associated fatty liver disease in nonobese patients without type 2 diabetes mellitus. American Journal of Physiology-Endocrinology and Metabolism. 325(1). E62–E71. 2 indexed citations

10.

Peng, Hongye, et al.. (2023). Correlation between the Severity of Metabolic Dysfunction-Associated Fatty Liver Disease and Serum Uric Acid to Serum Creatinine Ratio. International Journal of Endocrinology. 2023. 1–8. 6 indexed citations

11.

Xu, Feiya, Jixiang Liu, Dingyi Wang, et al.. (2023). Risk factors for venous thromboembolism in patients with pneumonia in the pre-COVID-19 era: a meta-analysis and systematic review. Journal of Thoracic Disease. 15(12). 6697–6707. 3 indexed citations

12.

Chen, Shengsong, Tao Yu, Chenli Chang, et al.. (2022). Dynamic analysis of gene signatures in the progression of COPD. ERJ Open Research. 9(2). 343–2022. 5 indexed citations

13.

Liu, Jixiang, Ziyi Chang, Zhu Zhang, et al.. (2022). Clinical features and metabolic reprogramming of atherosclerotic lesions in patients with chronic thromboembolic pulmonary hypertension. Frontiers in Cardiovascular Medicine. 9. 1023282–1023282. 4 indexed citations

14.

Zhao, Qin, et al.. (2019). New Red Fluorescent Calcium Indicators for Functional Analysis of GPCRs and Ca2+ Channel Targets. Biophysical Journal. 116(3). 240a–240a. 1 indexed citations

15.

Cui, Jian, Jun Wang, Chao Lin, Jixiang Liu, & Wei Zuo. (2019). <p>Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells</p>. OncoTargets and Therapy. Volume 12. 10177–10185. 8 indexed citations

16.

Luo, Zhen, et al.. (2017). Detection of Reactive Oxygen Species in Live Cell Mitochondria. Biophysical Journal. 112(3). 132a–132a. 1 indexed citations

17.

Luo, Zhen, et al.. (2017). Fluorescent real-time quantitative measurements of intracellular peroxynitrite generation and inhibition. Analytical Biochemistry. 520. 44–48. 15 indexed citations

18.

Chang, Chao, Qingwei Ji, Bangwei Wu, et al.. (2015). Chemerin15‐Ameliorated Cardiac Ischemia‐Reperfusion Injury Is Associated with the Induction of Alternatively Activated Macrophages. Mediators of Inflammation. 2015(1). 563951–563951. 26 indexed citations

19.

Liu, Min, Jixiang Liu, Jinfang Liao, & Zhenjun Diwu. (2012). A Functional Analysis of GPCR and Calcium Channel Targets using Cal 520 AM Ester. Biophysical Journal. 102(3). 309a–310a. 2 indexed citations

20.

Du, Lanying, Xiujuan Zhang, Jixiang Liu, & Shibo Jiang. (2011). Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection. Journal of Visualized Experiments. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact